BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12669944)

  • 1. Understanding primary pulmonary hypertension.
    Berkowitz DS; Coyne NG
    Crit Care Nurs Q; 2003; 26(1):28-34. PubMed ID: 12669944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension: new perspectives.
    Nauser TD; Stites SW
    Congest Heart Fail; 2003; 9(3):155-62. PubMed ID: 12826774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.
    Steiner MK; Preston IR; Klinger JR; Criner GJ; Waxman AB; Farber HW; Hill NS
    Chest; 2006 Nov; 130(5):1471-80. PubMed ID: 17099026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the treatment of pediatric pulmonary artery hypertension.
    Barst RJ
    Pediatr Clin North Am; 1999 Apr; 46(2):331-45. PubMed ID: 10218078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bosentan.
    Chin K; Channick R
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):175-82. PubMed ID: 15151466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management of primary pulmonary hypertension.
    McLaughlin VV
    Expert Opin Pharmacother; 2002 Feb; 3(2):159-65. PubMed ID: 11829729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatments for pulmonary arterial hypertension].
    Montani D; Jaïs X; Ioos V; Sitbon O; Simonneau G; Humbert M
    Rev Med Interne; 2004 Oct; 25(10):720-31. PubMed ID: 15471598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic management of primary pulmonary hypertension].
    Chaouat A; Weitzenblum E
    Presse Med; 2002 Feb; 31(7):320-8. PubMed ID: 11899690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and emerging therapy for primary pulmonary hypertension.
    Pass SE; Dusing ML
    Ann Pharmacother; 2002 Sep; 36(9):1414-23. PubMed ID: 12196062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epoprostenol therapy for primary pulmonary hypertension.
    Cheever KH; Kitzes B; Genthner D
    Crit Care Nurse; 1999 Aug; 19(4):20-7. PubMed ID: 10614244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids.
    Hoeper MM; Taha N; Bekjarova A; Gatzke R; Spiekerkoetter E
    Eur Respir J; 2003 Aug; 22(2):330-4. PubMed ID: 12952269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of pulmonary arterial hypertension associated to systemic sclerosis].
    Hachulla E
    Rev Med Interne; 2004 Mar; 25(3):195-200. PubMed ID: 15049280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing and treating primary pulmonary hypertension.
    Frazier SK
    Nurse Pract; 1999 Sep; 24(9):18, 21-2, 25-6 passim; quiz 42-3. PubMed ID: 10507069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disproportionate pulmonary hypertension in a patient with early-onset pulmonary emphysema treated with specific drugs for pulmonary arterial hypertension.
    Shimizu M; Imanishi J; Takano T; Miwa Y
    Intern Med; 2011; 50(20):2341-6. PubMed ID: 22001462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New hope for patients with pulmonary hypertension: endothelin receptor antagonists: update for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2004; 18(5):232-4. PubMed ID: 15540063
    [No Abstract]   [Full Text] [Related]  

  • 16. Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.
    Benza RL; Rayburn BK; Tallaj JA; Pamboukian SV; Bourge RC
    Chest; 2008 Jul; 134(1):139-45. PubMed ID: 18403673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bosentan: new preparation. Pulmonary hypertension: an option before epoprostenol infusion.
    Prescrire Int; 2005 Apr; 14(76):47-50. PubMed ID: 15875338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoprostenol in primary pulmonary hypertension.
    Herner SJ; Mauro LS
    Ann Pharmacother; 1999 Mar; 33(3):340-7. PubMed ID: 10200860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in patients with pulmonary arterial hypertension treated with first-line bosentan.
    McLaughlin VV
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():10-5. PubMed ID: 16919005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.